Rights and permissions
About this article
Cite this article
Osteoarthritis drugs market to be driven by COX-2 inhibitors. Pharmacoecon. Outcomes News 331, 11 (2001). https://doi.org/10.1007/BF03269608
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269608